Carlyle Group Inc. - 18 Feb 2026 SCHEDULE 13D/A Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR)

Filing Manager
Carlyle Group Inc.
Reporting Manager
The Carlyle Group Inc.
Security
Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
JSPR
Shares outstanding
28,639,737 shares
Disclosed Ownership
1,088,310 shares
Ownership
3.8%
Form type
SCHEDULE 13D/A
Filing time
18 Feb 2026, 17:29:20 UTC
Date of event
18 Feb 2026
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Carlyle Group Inc. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Corporate Secretary 0001527166
Carlyle Holdings I GP Inc. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001548626
Carlyle Holdings I GP Sub L.L.C. 3.8% 1,088,310 0 1,088,310 By: Carlyle Holdings I GP Inc., its sole member, /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001548627
Carlyle Holdings I L.P. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001548628
CG Subsidiary Holdings L.L.C. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001790577
TC Group, L.L.C. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0000933790
Carlyle Investment Management L.L.C. 3.8% 1,088,310 0 1,088,310 /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001354120
Carlyle Genesis UK LLC 3.8% 1,088,310 0 1,088,310 By: Carlyle Investment Management L.L.C., its sole member, /s/ Anne K. Frederick Anne K. Frederick, Managing Director 0001941860
Abingworth LLP 3.8% 1,088,310 0 1,088,310 /s/ Emma O'Reilly Emma O'Reilly, Authorized Signatory 0001397144
Abingworth Bioventures VII LP 3.8% 1,088,310 0 1,088,310 /s/ Emma O'Reilly Emma O'Reilly, Authorized Signatory 0001688313